Disease/Infection News

RSS

Hispanic immigrants of working age more likely to die of COVID-19 than non-Hispanics

Hispanic immigrants of working age -- 20 to 54 years old -- are over 11 times more likely to die of COVID-19 than U.S.-born men and women who are not Hispanic, according to a USC study of California death certificate data from 2020.

8 Apr 2021

Study finds more children infected by coronavirus during the second wave in Germany

A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests.

8 Apr 2021

Autoantibodies may contribute to severe COVID-19 and potential long-COVID-19 symptoms

New research in the USA and China. investigated how autoantibodies could mediate NETs during a COVID-19 infection. Extensive damage to the body from neutrophil extracellular traps (NETs) after infection may be contributing to thromboinflammation and the symptoms experienced by COVID-19 ‘long-haulers’.

8 Apr 2021

Moderna COVID-19 vaccine ensures long-term protection against SARS-CoV-2 infection, suggests study

A recent report published in the New England Journal of Medicine has revealed that the COVID-19 vaccine developed by Moderna, Inc, USA, is capable of inducing robust and durable antibody responses for at least six months post-vaccination.

8 Apr 2021

Increasing compliance with existing restrictions can stop the spread of COVID-19 virus, says expert

Responses from 9 500 inhabitants in 11 countries in a study financed by the EU have given the researchers an insight into how governments should act to stop the spread of the virus.

8 Apr 2021

Prefusion SARS-CoV-2 spike-based vaccine candidate shows high safety and efficacy in phase I trial

A new preprint research paper posted to the medRxiv server reports the results of the first human trial of the prefusion stabilized SARS-CoV-2 spike vaccine MVC-COV1901 in Taiwan.

8 Apr 2021

Mouse monoclonal antibodies protect against SARS-CoV-2 wildtype, UK and South African variants

A new preprint research paper posted to the bioRxiv server reports on the ability of a set of neutralizing mouse antibodies to protect mice against multiple lineages of SARS-CoV-2.

8 Apr 2021

Better masks, adequate ventilation can reduce spread of COVID-19 virus in enclosed spaces

With research increasingly showing the COVID-19 virus is transmissible via smaller droplets suspended in air, there is a growing concern current public health guidelines of mask wearing and social distancing are insufficient in combating its spread in indoor environments, like prisons, hospitals, and meatpacking plants, where people tend to be in close quarters.

8 Apr 2021

Landmark discovery may lead to safe, effective antiviral drugs against COVID-19

The COVID-19 vaccines currently rolling out are providing hope that the spread of the disease can be halted. But infection rates are still high, and for those who contract COVID-19, the search for effective treatments remains important.

8 Apr 2021

Leaky gut and microbial dysbiosis could contribute to cytokine storm in severely ill COVID-19 cases

The gut is a well-established route of infection and target for viral damage by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for COVID-19. This is supported by the clinical observation that about half of COVID-19 patients exhibit gastrointestinal (GI) symptoms.

8 Apr 2021

Smartphone mobility tracking strongly predicts COVID-19 outbreaks

Mobility tracking using cell phone data showing greater movement of people is a strong predictor of increased rates of COVID-19, according to new data in CMAJ (Canadian Medical Association Journal)

8 Apr 2021

Study: 1 in 10 people still has moderate to severe symptoms after mild COVID-19

Eight months after mild COVID-19, one in ten people still has at least one moderate to severe symptom that is perceived as having a negative impact on their work, social or home life. The most common long-term symptoms are a loss of smell and taste and fatigue.

8 Apr 2021

Hospital pandemic policies had negative outcomes in maternity patients, nurses

With a lethal, airborne virus spreading fast, hospitals had to change how they treated patients and policies for how caregivers provided that treatment. But for maternity patients and nurses some of those changes had negative outcomes, according to a new University of Washington study.

8 Apr 2021

Majority of New Zealanders see a silver lining to COVID-19 lockdown

Two thirds of New Zealanders believed there were 'silver linings' to the country's Alert Level 4 COVID-19 lockdown imposed in March last year, a University of Otago survey has found.

8 Apr 2021

Little evidence of COVID-19 vaccine nationalism in public opinion

Invariably, vaccination programs in high-income countries (HICs) are in a much better position due to their ability to secure a greater number of vaccines from multiple companies. On the contrary, lower-income countries have failed to obtain a sufficient number of vaccines.

8 Apr 2021

The interaction between blood clotting and SARS-CoV-2 infection

Coagulopathy - a condition in which the blood's ability to clot is impaired, is recognized as a significant aspect of morbidity in COVID-19 patients. In a recent study, Prof Lewis Cantley and a team of researchers explored the role of coagulation factors in the SARS-CoV-2 infection. Their recent study is posted on the bioRxiv server.

7 Apr 2021

Real-world proof Pfizer and Moderna mRNA vaccines prevent SARS-CoV-2 infection

A new Morbidity and Mortality Weekly Report published by the U.S. Centers for Disease Control and Prevention (CDC) states that mRNA COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infection in the real world. The report is based on a CDC study where it routinely tested prospective cohorts of health care professionals, first responders, and essential and frontline workers for SARS-CoV-2 infections.

7 Apr 2021

Bispecific antibodies neutralize SARS-CoV-2 and its variants

A new bioRxiv preprint study led by Joshua Tan from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, involves generating bispecific antibodies using a new method cross-linking the antibodies with adjacent spike proteins using dual N-terminal domain/receptor binding domain specificity.

7 Apr 2021

Evidence of monoclonal antibodies effectively neutralizing SARS-CoV-2 variants

Makdasi et al. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants. bioRxiv, 2021. doi: https://doi.org/10.1101/2021.04.01.438035, https://www.biorxiv.org/content/10.1101/2021.04.01.438035v2

7 Apr 2021

Michigan Medicine to kick off first national study on allergic reactions to COVID-19 vaccines

In a carefully controlled study, Michigan Medicine researchers will kick off the first national trial to study allergic reactions to the COVID-19 mRNA vaccines.

7 Apr 2021

Disease/Infection News

Hispanic immigrants of working age more likely to die of COVID-19 than non-Hispanics

Study finds more children infected by coronavirus during the second wave in Germany

Autoantibodies may contribute to severe COVID-19 and potential long-COVID-19 symptoms

Moderna COVID-19 vaccine ensures long-term protection against SARS-CoV-2 infection, suggests study

Increasing compliance with existing restrictions can stop the spread of COVID-19 virus, says expert

Prefusion SARS-CoV-2 spike-based vaccine candidate shows high safety and efficacy in phase I trial

Mouse monoclonal antibodies protect against SARS-CoV-2 wildtype, UK and South African variants

Better masks, adequate ventilation can reduce spread of COVID-19 virus in enclosed spaces

Landmark discovery may lead to safe, effective antiviral drugs against COVID-19

Leaky gut and microbial dysbiosis could contribute to cytokine storm in severely ill COVID-19 cases

Smartphone mobility tracking strongly predicts COVID-19 outbreaks

Study: 1 in 10 people still has moderate to severe symptoms after mild COVID-19

Hospital pandemic policies had negative outcomes in maternity patients, nurses

Majority of New Zealanders see a silver lining to COVID-19 lockdown

Little evidence of COVID-19 vaccine nationalism in public opinion

The interaction between blood clotting and SARS-CoV-2 infection

Real-world proof Pfizer and Moderna mRNA vaccines prevent SARS-CoV-2 infection

Bispecific antibodies neutralize SARS-CoV-2 and its variants

Evidence of monoclonal antibodies effectively neutralizing SARS-CoV-2 variants

Michigan Medicine to kick off first national study on allergic reactions to COVID-19 vaccines

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News